Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
LaunchCyrus Biotechnology presents its cutting-edge protein engineering capabilities and IgG protease candidate at the Hit ID Summit.
Nov 11, 2024
SeattleInformation TechnologyBiotechnology
Product Description
Cyrus Biotechnology showcased its innovative hybrid AI/screening platform for biologics discovery and presented its best-in-class IgG-degrader candidate for autoimmune disease and gene therapy pre-treatment at the Hit ID Summit in Boston.
Company Information
Company
Cyrus Biotechnology, Inc.
Location
1201 2nd Ave, Suite 900
Seattle, Washington, United States
About
Cyrus Biotechnology is a pre-clinical-stage biotech company combining protein design and screening to create novel biologics for serious unmet medical needs. Using this approach, we are developing an early pipeline of innovative programs in multiple indications. We are also partnering with leading biotech and pharma companies and research institutes to bring collaborative programs forward from discovery to the clinic.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cyrus Biotechnology, Inc. ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.